1993
DOI: 10.3109/09637489309017433
|View full text |Cite
|
Sign up to set email alerts
|

Fish oils, eicosanoid biosynthesis and cardiovascular disease: An overview

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
1
4

Year Published

1996
1996
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 66 publications
0
5
1
4
Order By: Relevance
“…This was also observed in our study. Surprisingly, we did not observe any significant decrease in plasma TGs in the rats fed n-3 PUFAs, contrary to data reported in human clinical studies (4,44,47). In humans, this effect is usually attributed to EPA (13,49), and, in this study, plasma TGs were lower in the EPA group, although this difference was not significant.…”
Section: Discussioncontrasting
confidence: 99%
“…This was also observed in our study. Surprisingly, we did not observe any significant decrease in plasma TGs in the rats fed n-3 PUFAs, contrary to data reported in human clinical studies (4,44,47). In humans, this effect is usually attributed to EPA (13,49), and, in this study, plasma TGs were lower in the EPA group, although this difference was not significant.…”
Section: Discussioncontrasting
confidence: 99%
“…Fish oil is a good source of n-3 fatty acids and is known to be an immune-enhancing component. It has been reported that fish oil helps maintain the intestinal permeability (Turley and Strain, 1993;Wild et al, 1997;Bancroft et al, 2003;Kreymann et al, 2006), which normally undergoes disruption following burn injury. Hence, the lipids of DEF-BP were enriched with fish oil.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, the composition of lipid, namely the proportion of polyunsaturated fatty acids (PUFA) with special reference to the ratio between n-6 and n-3 fatty acids (Narshimha Rao, 1993;Turley and Strain, 1993;Grester, 1995;Roy et al, 2004;Farreras et al, 2005), structured glycerides (Sandstorm et al, 1995;Roy et al, 2004), and medium-chain triglycerides (Ledeboer et al, 1995) is required to be incorporated in appropriate proportion. The beneficial effects of dietary fiber in normal nutrition are being extended to enteral nutrition (Cummings et al, 1980;Rushdi et al, 2004).…”
Section: Formulation Of Enteral Foods Introductionmentioning
confidence: 99%
“…The content of SFAs in a human diet determines the cholesterol level in the blood serum. One of the indicators of the health quality of a food product is the intake of polyunsaturated fatty acids (PUFAs) and the n-6/n-3 fatty acids ratio, which, according to dieticians (Turley & Strain, 1993), should be in the range of 4 -6 : 1. According to the latest nutritional recommendations, saturated fatty acids should cover not more than 10% of daily energy demand.…”
Section: Discussionmentioning
confidence: 99%